Skip to main content
. Author manuscript; available in PMC: 2016 Dec 2.
Published in final edited form as: Ther Innov Regul Sci. 2016 Nov;50(6):705–709. doi: 10.1177/2168479016656030

Figure 2.

Figure 2

The distribution of single-patient INDs, both emergency (eIND) and nonemergency (SPIND), across the review divisions in the Office of New Drugs within CDER. The totals shown represents the addition of both emergency and nonemergency INDs. IND, investigational new drug.